Page last updated: 2024-09-04

cyc 202 and deoxyglucose

cyc 202 has been researched along with deoxyglucose in 1 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (deoxyglucose)	Trials (deoxyglucose)	Recent Studies (post-2010) (deoxyglucose)
979	7	393	11,426	171	1,375

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lalioti, V; Muruáis, G; Sandoval, IV	1

Other Studies

1 other study(ies) available for cyc 202 and deoxyglucose

Article	Year
The Cdk5 inhibitor roscovitine strongly inhibits glucose uptake in 3T3-L1 adipocytes without altering GLUT4 translocation from internal pools to the cell surface. Journal of cellular physiology, 2009, Volume: 220, Issue:1 Topics: 3T3-L1 Cells; Adipocytes; Animals; Biological Transport; Cell Membrane; Cyclin-Dependent Kinase 5; Deoxyglucose; Dose-Response Relationship, Drug; Glucose Transporter Type 4; Insulin; Mice; Protein Kinase Inhibitors; Protein Transport; Purines; Roscovitine; Time Factors	2009

Article

Year

The Cdk5 inhibitor roscovitine strongly inhibits glucose uptake in 3T3-L1 adipocytes without altering GLUT4 translocation from internal pools to the cell surface.

Journal of cellular physiology, 2009, Volume: 220, Issue:1

Topics: 3T3-L1 Cells; Adipocytes; Animals; Biological Transport; Cell Membrane; Cyclin-Dependent Kinase 5; Deoxyglucose; Dose-Response Relationship, Drug; Glucose Transporter Type 4; Insulin; Mice; Protein Kinase Inhibitors; Protein Transport; Purines; Roscovitine; Time Factors

2009